Off-label Use of Gastrointestinal Multiplex PCR Panel for the Diagnosis of Amoebic Liver Abscess: A Three-case Pediatric Report - Summary - MDSpire

Off-label Use of Gastrointestinal Multiplex PCR Panel for the Diagnosis of Amoebic Liver Abscess: A Three-case Pediatric Report

  • By

  • Michael Muñoz-Rosa

  • Natalia Arango-Serna

  • Juan Mesa-Monsalve

  • Alejandro Diaz-Diaz

  • October 15, 2025

  • 0 min

Share

Objective:

To report the use of a multiplex PCR panel for the rapid diagnosis of amoebic liver abscess in pediatric patients, highlighting its potential impact on treatment outcomes.

Key Findings:
  • The multiplex PCR panel confirmed E. histolytica in all three cases, leading to timely and targeted antiamoebic therapy.
  • Timely diagnosis allowed for improved patient outcomes.
  • The approach highlights potential utility in resource-limited settings.
Interpretation:

The off-label use of the GIFA panel for diagnosing amoebic liver abscesses demonstrates its effectiveness in providing rapid and accurate results, which is critical for initiating appropriate treatment, though further validation is necessary.

Limitations:
  • The use of the GIFA panel in this manner is unvalidated and requires further investigation, with limited evidence for off-label applications of the technology.
Conclusion:

The study suggests that the GIFA panel can be a valuable tool for diagnosing amoebic liver abscesses, particularly in settings with high prevalence and limited resources, but further studies are needed to support these findings.

Original Source(s)

Related Content